• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统评价报告结局测量工具(OMIs)的指南:PRISMA-COSMIN 对 OMIs 的 2024 年修订版。

Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.

机构信息

Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.

Department of Epidemiology and Data Science, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, Netherlands.

出版信息

Health Qual Life Outcomes. 2024 Jul 9;22(1):48. doi: 10.1186/s12955-024-02256-9.

DOI:10.1186/s12955-024-02256-9
PMID:38978063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11232333/
Abstract

PURPOSE

Although comprehensive and widespread guidelines on how to conduct systematic reviews of outcome measurement instruments (OMIs) exist, for example from the COSMIN (COnsensus-based Standards for the selection of health Measurement INstruments) initiative, key information is often missing in published reports. This article describes the development of an extension of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guideline: PRISMA-COSMIN for OMIs 2024.

METHODS

The development process followed the Enhancing the QUAlity and Transparency Of health Research (EQUATOR) guidelines and included a literature search, expert consultations, a Delphi study, a hybrid workgroup meeting, pilot testing, and an end-of-project meeting, with integrated patient/public involvement.

RESULTS

From the literature and expert consultation, 49 potentially relevant reporting items were identified. Round 1 of the Delphi study was completed by 103 panelists, whereas round 2 and 3 were completed by 78 panelists. After 3 rounds, agreement (≥ 67%) on inclusion and wording was reached for 44 items. Eleven items without consensus for inclusion and/or wording were discussed at a workgroup meeting attended by 24 participants. Agreement was reached for the inclusion and wording of 10 items, and the deletion of 1 item. Pilot testing with 65 authors of OMI systematic reviews further improved the guideline through minor changes in wording and structure, finalized during the end-of-project meeting. The final checklist to facilitate the reporting of full systematic review reports contains 54 (sub)items addressing the review's title, abstract, plain language summary, open science, introduction, methods, results, and discussion. Thirteen items pertaining to the title and abstract are also included in a separate abstract checklist, guiding authors in reporting for example conference abstracts.

CONCLUSION

PRISMA-COSMIN for OMIs 2024 consists of two checklists (full reports; abstracts), their corresponding explanation and elaboration documents detailing the rationale and examples for each item, and a data flow diagram. PRISMA-COSMIN for OMIs 2024 can improve the reporting of systematic reviews of OMIs, fostering their reproducibility and allowing end-users to appraise the quality of OMIs and select the most appropriate OMI for a specific application. NOTE: In order to encourage its wide dissemination this article is freely accessible on the web sites of the journals: Health and Quality of Life Outcomes; Journal of Clinical Epidemiology; Journal of Patient-Reported Outcomes; Quality of Life Research.

摘要

目的

尽管关于如何进行结局测量工具(OMI)系统评价的全面、广泛的指南已经存在,例如来自 COSMIN(COnsensus-based Standards for the selection of health Measurement INstruments)倡议的指南,但在已发表的报告中,往往会缺少关键信息。本文描述了对系统评价和荟萃分析的首选报告项目(PRISMA)2020 指南的扩展:用于 2024 年 OMI 的 PRISMA-COSMIN 的制定过程。

方法

该开发过程遵循增强健康研究质量和透明度(EQUATOR)指南,并包括文献检索、专家咨询、德尔菲研究、混合工作组会议、试点测试和项目结束会议,同时纳入了患者/公众的参与。

结果

从文献和专家咨询中,确定了 49 个潜在相关的报告项目。德尔菲研究第一轮有 103 名专家参与,第二轮和第三轮有 78 名专家参与。经过 3 轮,有 44 个项目达成了纳入和措辞的共识(≥67%)。11 个项目未达成纳入和/或措辞的共识,在由 24 名参与者参加的工作组会议上进行了讨论。10 个项目的纳入和措辞达成了共识,删除了 1 个项目。对 65 名 OMI 系统评价作者进行的试点测试通过对措辞和结构进行细微的更改,进一步完善了指南,并在项目结束会议上定稿。最终的核对清单可促进全面系统评价报告的报告,其中包含 54 个(子)项目,涵盖了综述的标题、摘要、通俗易懂的摘要、开放科学、引言、方法、结果和讨论。13 个与标题和摘要相关的项目也包含在单独的摘要核对清单中,指导作者报告例如会议摘要。

结论

用于 2024 年 OMI 的 PRISMA-COSMIN 由两个核对清单(完整报告;摘要)、它们相应的解释和阐述文件组成,详细说明了每个项目的基本原理和示例,以及一个数据流程图。用于 2024 年 OMI 的 PRISMA-COSMIN 可以提高 OMI 系统评价的报告质量,促进其可重复性,并使最终用户能够评估 OMI 的质量,并为特定应用选择最合适的 OMI。

注

为了鼓励广泛传播,本文在以下期刊的网站上免费提供:健康与生活质量结果杂志;临床流行病学杂志;患者报告结局杂志;生活质量研究杂志。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/11232333/b1879f5f8a13/12955_2024_2256_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/11232333/0b85ca5574fd/12955_2024_2256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/11232333/c4674f468605/12955_2024_2256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/11232333/b1879f5f8a13/12955_2024_2256_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/11232333/0b85ca5574fd/12955_2024_2256_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/11232333/c4674f468605/12955_2024_2256_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ecf/11232333/b1879f5f8a13/12955_2024_2256_Fig3_HTML.jpg

相似文献

1
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.系统评价报告结局测量工具(OMIs)的指南:PRISMA-COSMIN 对 OMIs 的 2024 年修订版。
Health Qual Life Outcomes. 2024 Jul 9;22(1):48. doi: 10.1186/s12955-024-02256-9.
2
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:2024 年 OMIs 的 PRISMA-COSMIN。
J Patient Rep Outcomes. 2024 Jul 9;8(1):64. doi: 10.1186/s41687-024-00727-7.
3
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:PRISMA-COSMIN 2024 版。
Qual Life Res. 2024 Aug;33(8):2029-2046. doi: 10.1007/s11136-024-03634-y. Epub 2024 Jul 9.
4
Guideline for reporting systematic reviews of outcome measurement instruments (OMIs): PRISMA-COSMIN for OMIs 2024.报告结局测量工具(OMIs)系统评价的指南:PRISMA-COSMIN 2024 年 OMIs 版。
J Clin Epidemiol. 2024 Sep;173:111422. doi: 10.1016/j.jclinepi.2024.111422. Epub 2024 Jul 9.
5
Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.制定、试行和传播 PRISMA-COSMIN 指南的研究方案:一种用于系统评价结果测量工具的新报告指南。
Syst Rev. 2022 Jun 13;11(1):121. doi: 10.1186/s13643-022-01994-5.
6
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.诊断测试准确性研究的系统评价和荟萃分析的首选报告项目:PRISMA-DTA 声明。
JAMA. 2018 Jan 23;319(4):388-396. doi: 10.1001/jama.2017.19163.
7
A blueprint for patient and public involvement in the development of a reporting guideline for systematic reviews of outcome measurement instruments: PRISMA-COSMIN for OMIs 2024.患者及公众参与制定结局测量工具系统评价报告指南的蓝图:2024年OMIs的PRISMA-COSMIN
Res Involv Engagem. 2024 Mar 21;10(1):33. doi: 10.1186/s40900-024-00563-5.
8
Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.医疗干预措施系统评价概述报告规范:PRIOR 声明的制定。
BMJ. 2022 Aug 9;378:e070849. doi: 10.1136/bmj-2022-070849.
9
Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.测量失语症试验中的沟通情况作为核心结局指标:ROMAA-2 国际核心结局集开发会议的结果。
Int J Lang Commun Disord. 2023 Jul-Aug;58(4):1017-1028. doi: 10.1111/1460-6984.12840. Epub 2022 Dec 30.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Patient-reported outcome measures for fatigue in patients with chronic kidney disease: a systematic review.慢性肾脏病患者疲劳的患者报告结局指标:一项系统评价
BMJ Open. 2025 Jul 16;15(7):e099592. doi: 10.1136/bmjopen-2025-099592.
2
A systematic review of patient-reported outcome measures (PROMs) to assess health-related quality of life (HRQoL) for breast cancer patients who are undertaking adjuvant endocrine therapy.一项关于患者报告结局指标(PROMs)的系统评价,以评估接受辅助内分泌治疗的乳腺癌患者的健康相关生活质量(HRQoL)。
Qual Life Res. 2025 Jun 18. doi: 10.1007/s11136-025-04004-y.
3
Comparability, acceptability and longitudinal adherence with digital emPHasis-10 in pulmonary arterial hypertension.

本文引用的文献

1
A blueprint for patient and public involvement in the development of a reporting guideline for systematic reviews of outcome measurement instruments: PRISMA-COSMIN for OMIs 2024.患者及公众参与制定结局测量工具系统评价报告指南的蓝图:2024年OMIs的PRISMA-COSMIN
Res Involv Engagem. 2024 Mar 21;10(1):33. doi: 10.1186/s40900-024-00563-5.
2
The psychometric and pragmatic evidence rating scale (PAPERS) for measure development and evaluation.用于测量工具开发与评估的心理测量和实用证据评级量表(PAPERS)。
Implement Res Pract. 2021 Aug 10;2:26334895211037391. doi: 10.1177/26334895211037391. eCollection 2021 Jan-Dec.
3
肺动脉高压中数字式emPHasis-10的可比性、可接受性及长期依从性
Eur Respir J. 2025 Jun 19;65(6). doi: 10.1183/13993003.00198-2025. Print 2025 Jun.
4
Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework.肺动脉高压临床试验中患者报告结局指标的选择:一项系统评价、荟萃分析及健康相关生活质量框架
Eur Respir Rev. 2025 May 14;34(176). doi: 10.1183/16000617.0006-2025. Print 2025 Apr.
5
COSMIN reporting guideline for studies on measurement properties of patient‑reported outcome measures: version 2.0.患者报告结局指标测量属性研究的COSMIN报告指南:第2.0版。
Qual Life Res. 2025 Mar 28. doi: 10.1007/s11136-025-03950-x.
Reporting guidelines used varying methodology to develop recommendations.
报告指南使用了不同的方法来制定建议。
J Clin Epidemiol. 2023 Jul;159:246-256. doi: 10.1016/j.jclinepi.2023.03.018. Epub 2023 Mar 24.
4
Guidelines for Reporting Outcomes in Trial Protocols: The SPIRIT-Outcomes 2022 Extension.试验方案中报告结果的指南:SPIRIT-结果2022扩展版
JAMA. 2022 Dec 20;328(23):2345-2356. doi: 10.1001/jama.2022.21243.
5
Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.试验报告中结果报告指南:CONSORT-结果2022扩展版
JAMA. 2022 Dec 13;328(22):2252-2264. doi: 10.1001/jama.2022.21022.
6
Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement.医疗干预措施系统评价概述报告规范:PRIOR 声明的制定。
BMJ. 2022 Aug 9;378:e070849. doi: 10.1136/bmj-2022-070849.
7
Study protocol for developing, piloting and disseminating the PRISMA-COSMIN guideline: a new reporting guideline for systematic reviews of outcome measurement instruments.制定、试行和传播 PRISMA-COSMIN 指南的研究方案:一种用于系统评价结果测量工具的新报告指南。
Syst Rev. 2022 Jun 13;11(1):121. doi: 10.1186/s13643-022-01994-5.
8
Systematic review on the measurement properties of diabetes-specific patient-reported outcome measures (PROMs) for measuring physical functioning in people with type 2 diabetes.系统评价:2 型糖尿病患者身体机能测量的糖尿病患者报告结局测量(PROM)的测量特性。
BMJ Open Diabetes Res Care. 2022 Jun;10(3). doi: 10.1136/bmjdrc-2021-002729.
9
The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review.数字监测设备在 COPD 患者的血氧饱和度和呼吸率监测中的性能:一项系统评价。
COPD. 2021 Aug;18(4):469-475. doi: 10.1080/15412555.2021.1945021. Epub 2021 Jul 5.
10
COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures.CONSORT 报告规范:用于评估患者报告结局测量工具测量属性的研究。
Qual Life Res. 2021 Aug;30(8):2197-2218. doi: 10.1007/s11136-021-02822-4. Epub 2021 Apr 5.